Supply of interventional cardiologists and the provision of lower-value Percutaneous Coronary Interventions (PCI)

Adam Gaffney1,2,3, Kelsey Chalmers3, David U Himmelstein1,4

  • 1Harvard Medical School, Boston, Massachusetts, United States of America.

Plos One
|July 22, 2026
PubMed

Insights

Higher numbers of heart procedure providers correlate with increased use of lower-value percutaneous coronary interventions (PCI). This suggests health planning can help align workforce supply with community needs to reduce unnecessary procedures and costs.

Area of Science:

  • Cardiovascular Medicine
  • Health Services Research
  • Health Economics

Background:

  • Percutaneous coronary interventions (PCI) are vital for acute coronary syndromes but offer less value for stable coronary artery disease (CAD).
  • Previous research indicates provider supply influences healthcare utilization, but its impact on lower-value PCI is unclear.

Purpose of the Study:

  • To investigate the relationship between the regional availability of PCI-performing physicians and the utilization of PCI procedures.
  • To determine if a higher supply of physicians performing PCI is associated with an increased rate of lower-value PCI procedures.

Main Methods:

  • Cross-sectional study utilizing 100% Medicare fee-for-service (FFS) and Medicare Advantage (MA) claims data from 2019-2021.
  • Examined PCI use and lower-value PCI provision (defined as PCI for stable CAD) at hospital and regional (Hospital Referral Region - HRR) levels.
  • Assessed the association between PCI provider density per million population and PCI utilization outcomes.

Main Results:

  • Hospitals in regions with the highest PCI provider density had a significantly higher rate of lower-value PCI provision (22.6%) compared to those in the lowest density regions (17.3%).
  • In fully adjusted models, higher provider density was linked to a 5.77 percentage point increase in lower-value PCI rates.
  • Both overall PCI use and lower-value PCI use increased with greater regional PCI provider density.

Conclusions:

  • The regional supply of PCI providers is associated with both the overall use of PCI and the use of lower-value PCI among Medicare beneficiaries.
  • Findings support the need for health workforce planning to match provider supply with community health needs, potentially reducing healthcare costs and low-value care.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...